Other News

We hear from the European Federation of Neurological Associations – EFNA on the special sessions being organised at the upcoming 5th EAN Congress taking place in Oslo, Norway (June 29 – July2, 2019).

In the continuity of the Value of Treatment research activities, new case studies have been developed on new therapeutic areas. On March 26th, May 23rd and September 24th 2018, EBC in collaboration with the European Academy of Neurology (EAN) and the European Federation of Neurological Associations (EFNA) launched a second round “VoT2” of case studies on Rare Neurological Disorders (RNDs) focusing upon Ataxia, Dystonia and Phenylketonuria

In 2018, STOA completed two Scientific Foresight projects, on assistive technologies for people with disabilities, and on 3D bio-printing for medical and enhancement purposes, while preparing the ground for a new project on alternative options for crop protection in farming practices.

READING RECCOMENDATIONS: NEWS FROM OTHER SOCIETIES

Publication on the roles of the medical profession and the industry on CME The BioMedical Alliance is a unique organisation representing 30 leading European medical societies (including EAN) that together represent more than 400,000 researchers and health professionals.

Prof. Gunther Deuschl’s, EAN Past-President, outstanding contribution to the movement disorders field was awarded during the 2019 AAN Congress in Philadelphia (PA), on May 6.

The ataxia diagnostic flowchart has been developed by members of the European Reference Network for Rare Neurological Diseases (ERN-RND) in order to help guide diagnosis.

On 27 March, the European Parliament and the Council reached an agreement on the EU's future framework programme for research and innovation, the Horizon Europe.

The Brain, Mind and Pain (BMP) initiative has today launched its Book of Evidence for the 2019-2024 European Parliament term.

The publication “SumEMos: Análisis y propuestas para contribuir a normalizar la vida con EM” integrates all voices from the Multiple Sclerosis community in Spain. The document was released in the last weeks in conclusion of last year’s “SumEMos para normalizar la vida con EM” conference on 4 October.

ECNP Networks and Thematic Working Groups (TWGs)

On 31 January 2019 , the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Ajovy©, intended for prophylaxis of migraine. The applicant for this medicinal product is Teva GmbH. The active substance is fremanezumab which is an antibody that works by binding to calcitonin gene-related peptide (CGRP). It is classified as an analgesic.

The 2019 Congress of the Academy for Multidisciplinary Neurotraumatology took place between April 11-12 in Cluj-Napoca, Romania, organized by the Foundation of the Society for the Study of Neuroprotection and Neuroplasticity and its partners.

On 21 March (Madrid, Spain), the new Innovative Medicines Initiative (IMI) coordination and support action entitled “Efficiently Networking European Neurodegeneration Research” (NEURONET) held its kick-off meeting.

The BioMed Alliance has provided feedback to the public consultation on Plan S, the initiative of the European Commission, Research Funding Organisations and Science Europe to promote open access publishing.